Cariprazine and Cenobamate: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Cenobamate
Cariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed Xcopri (cenobamate) and Vraylar (cariprazine) together. Cenobamate can speed up the liver enzyme (called CYP3A4) that both builds and breaks down cariprazine. Cariprazine, your mental health medicine, relies on this enzyme to work the way it should.
Because that enzyme handles both making and clearing cariprazine's active forms, the overall effect is hard to predict, and this hasn't been formally studied. That's why it's flagged as something to watch. The good news is your care team can manage this. Keep taking both exactly as prescribed, and let your doctor or pharmacist know if your symptoms change so they can adjust and monitor as needed.
Mechanism: Cenobamate is a CYP3A4 inducer; cariprazine is a CYP3A4 substrate. CYP3A4 governs both formation and elimination of cariprazine's active metabolites (desmethyl- and didesmethyl-cariprazine), so the net effect on total active exposure is indeterminate.
- Direction: Unclear (induction affects both activation and clearance of active moieties).
- Magnitude: Not evaluated.
- Onset: Unspecified (induction typically develops over 1 to 2 weeks).
- Evidence: Theoretical.
- Management: Coadministration with a CYP3A4 inducer is not recommended per labeling. If combined, monitor closely for loss of efficacy or altered tolerability; individualize dosing per clinical response.
What happens
Effects on the cariprazine exposure has not been evaluated and the net effect is unclear
Interaction Deep Dive
Using cariprazine (which is metabolized by CYP3A4) together with a CYP3A4 inducer is not advised. The generation as well as the clearance of cariprazine's active metabolites depend on CYP3A4. How CYP3A4 inducers alter cariprazine exposure has not been studied, so the overall outcome remains uncertain1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
Cenobamate can change how your body handles cariprazine, and because the direction isn't predictable, combining them is generally not recommended. Your care team can still manage this safely.
- Keep taking both as prescribed unless your doctor tells you otherwise. Do not stop or change doses on your own.
- Your doctor may watch you more closely for changes in how well the cariprazine is working or for new side effects.
- Your dose may need to be adjusted and individualized by your care team, or an alternative may be considered.
- Report any return of symptoms or unusual effects to your pharmacist or prescriber.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Cariprazine and Cenobamate together?
Cenobamate may unpredictably change cariprazine levels, so this combination is generally not recommended; keep taking both as prescribed and ask your doctor or pharmacist whether monitoring or a change is needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cariprazine and Cenobamate interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Cariprazine and Cenobamate interaction managed?
Cenobamate can change how your body handles cariprazine, and because the direction isn't predictable, combining them is generally not recommended. Your care team can still manage this safely. Keep taking both as prescribed unless your doctor tells you otherwise. Do not stop or change doses on your own. Your doctor may watch you more closely for changes in how well the cariprazine is working or for… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Cariprazine or Cenobamate need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
Keep reading about Cenobamate
Keep reading about Cariprazine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist